HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,237-1,248 of 1,979
Drug study icon
CompletedNCT04417049

Treatment of Depression in bipolarity With Pentoxifylline

Official study title

Pentoxifylline for Bipolar Depression: A Proof-of-Concept Feasibility Study

This study has finished and is no longer accepting participants.

In Toronto
Bipolarity, DepressionMedication studyAges 18–65
Countries
Canada
Sponsor
University Health Network, Toronto
Drug study icon
TerminatedNCT00005015

Treatment of Depression in Youth With Bipolarity

Official study title

Fluoxetine for the Treatment of Major Depression in Youth With Bipolar Disorder _

This study ended early.

Location not clearly listed
Bipolarity, DepressionMedication studyAges 8–18
Countries
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Drug study icon
TerminatedNCT00272025

Treatment Resistant Depression in bipolarity

Official study title

Six Week Double Blind, Randomized Trial of Escitalopram Add On for Treatment Resistant Bipolar Depression

This study ended early.

In Kingston
Bipolarity, DepressionMedication studyAges 18–65
Countries
Canada
Sponsor
Queen's University
Other study type icon
CompletedNCT00664976

Treatment Resistant Depression for depression in bipolarity

Official study title

Treatment Resistant Depression in Bipolar Disorder - A Randomized Controlled Trial of Electroconvulsive Therapy

This study has finished and is no longer accepting participants.

Multiple locations, including Bergen
Bipolarity, DepressionInterventional studyAges 18+
Countries
Norway
Sponsor
Norwegian University of Science and Technology
Drug study icon
TerminatedNCT00947791

Treatment Study of Depression in bipolarity

Official study title

Intravenous Ketamine in Treatment-Resistant Bipolar Depression

This study ended early.

In New York
Bipolarity, DepressionMedication studyAges 21–70
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Behavioral study icon
CompletedNCT01470781

Treatment to Enhance Cognition in Bipolarity

Official study title

Efficacy of a Cognitive Remediation Treatment Program for Bipolar Disorder

This study has finished and is no longer accepting participants.

In Belmont
Bipolarity, SchizophreniaBehavioural studyAges 18–50
Countries
United States
Sponsor
Mclean Hospital (Hospital / academic medical center)
Drug study icon
TerminatedNCT00857818

Study Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in people with Schizophrenia or Bipolarity type I Who Have Metabolic Syndrome

Official study title

A 16-Week, Randomized, Controlled Trial of the Effect of Aripiprazole Versus Standard of Care on Non-HDL Cholesterol Among Patients With Schizophrenia and Bipolar I Disorder Who Have Pre-existing Metabolic Syndrome

This study ended early.

Multiple locations, including Calgary
Bipolarity, SchizophreniaMedication studyAges 18–65
Countries
Canada
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
WithdrawnNCT01768767

study of Ketamine and Lithium Therapy in Depression in bipolarity

What is this study about?

Researchers are comparing Ketamine/Lithium, ketamine and placebo to find out how the approaches affect depression symptoms in people with bipolarity during a depressive episode.

This study was withdrawn before enrollment.

Location not clearly listed
Bipolarity, DepressionMedication studyAges 18–65
Countries
Sponsor
Yale University
Drug study icon
CompletedNCT03872596

study to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolarity

Official study title

A Phase 1, 2-Part, Open-Label, Randomized, Crossover Pilot Trial to Assess the Relative Bioavailability of Quetiapine Versus Seroquel® 300-mg Oral Tablets in Subjects With Schizophrenia or Bipolar Disorder and 25-mg Oral Tablets in Healthy Subjects

This study has finished and is no longer accepting participants.

In Long Beach
Bipolarity, SchizophreniaMedication studyAges 18–45
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Behavioral study icon
Active Not RecruitingNCT07632989

Virtual Reality-Based Cognitive Remediation in Schizophrenia and Bipolarity

Official study title

FULL-MINDSET- Fully Immersive Virtual Reality-based Cognitive Training in Schizophrenia and Bipolar Disorder: a Single Blind Randomized Controlled Trial in a Real-world Setting

This study is no longer accepting new participants.

In Brescia
Bipolarity, SchizophreniaBehavioural studyAges 18+
Countries
Italy
Sponsor
Università degli Studi di Brescia

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.